Delivery Order SPE2DR25D3301-SPE2DR26F19RC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count supply) with a ceiling value of $2,271.36. This firm fixed-price delivery order, issued on September 8, 2025, is expected to be completed by September 29, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of YONSA 125 mg tablets (120-count units). This firm fixed-price delivery order, with an ultimate completion date of September 25, 2025, represents a non-set-aside procurement under open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of YONSA 125 mg tablets (120 count). This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, is to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation and represents a child contract under AmerisourceBergen's larger federal...
- The Defense Logistics Agency awarded a $4,787.34 delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Yonsa 125 mg tablets (120-count). This is a non-set-aside, competitively awarded contract with firm fixed pricing and a completion date of December 19, 2025. The pharmaceutical will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of YONSA (abiraterone acetate) 125 mg tablets in a quantity of 120 units, with a contract value of $4,787.34. This firm fixed-price delivery order, issued on December 2, 2025, with an ultimate completion date of December 23, 2025, is classified as non-set-aside and represents a competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Yonsa 125 mg tablets (120-count package) valued at $2,271.36 with a firm fixed price structure. This delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Yonsa 125 mg tablets (120-count units). This non-set-aside, competitively awarded contract carries a ceiling value of $14,362.02 and was executed on December 16, 2025, with an ultimate completion date of January 8, 2026. The contract employs firm fixed price terms and is classified as a delivery order, indicating...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of YONSA 125 mg tablets (120-count units) with a ceiling value of $2,271.36 and a firm fixed price structure. This non-set-aside delivery order is scheduled for completion by September 29, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order issued...
- The Defense Logistics Agency awarded a $2,271.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of YONSA 125 mg, a prescription medication used in oncology treatment. This non-set-aside contract was awarded on July 28, 2025, with an ultimate completion date of August 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count units) valued at $2,271.36 under a firm fixed price contract type. This non-competitive delivery order, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's corporate office location in...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19RCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of YONSA (yondelis) 125 mg tablets in a quantity of 120 units, with a ceiling value of $19,149.36. This firm fixed-price delivery order, awarded on December 17, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by January 9, 2026. The award supports the company's performance at its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC establishes AmerisourceBergen as a comprehensive pharmaceutical supplier for global military healthcare operations, enabling the company to deliver specialized medications, brand-name and generic drugs, vaccines, and medical supplies to support Defense Health Agency and other federal healthcare systems. This particular delivery order for YONSA, an oncology therapeutic agent, exemplifies the specialized pharmaceutical products supplied through this strategic vehicle serving the broader federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.1k | 12/16/25 |